dc.creatorCardoso, Liana Monteiro da Fonseca
dc.creatorMoreira, Lucio Filgueiras Pacheco
dc.creatorPinto, Marcelo Alves
dc.creatorHenriques-Pons, Andrea
dc.creatorAlves, Luiz Anastácio
dc.date2019-02-01T13:58:49Z
dc.date2019-02-01T13:58:49Z
dc.date2018
dc.date.accessioned2023-09-26T21:33:45Z
dc.date.available2023-09-26T21:33:45Z
dc.identifierCARDOSO, Liana Monteiro da Fonseca; et al. Domino Hepatocyte Transplantation: A Therapeutic Alternative for the Treatment of Acute Liver Failure. Canadian Journal of Gastroenterology and Hepatology, Volume 2018, Article 2593745, 9p, 2018.
dc.identifier2291-2789
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/31377
dc.identifier10.1155/2018/2593745
dc.identifier2291-2797
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8872823
dc.descriptionAcute liver failure (ALF) is a severe syndrome with an elevated mortality rate, ranging from 40 to 80 %. Currently, liver transplantation is the only definitive treatment for these patients and new therapies aiming to treat ALF include artificial organs implant and stem cells therapy, for example. However, a major limitation of liver donors exists. Living donor liver transplantation (LDLT), split liver transplantation (SLT), and domino liver transplantation (DLT) are some of the available alternatives to treat ALF patients, but these do not reduce the number of patients on waiting lists. Herein, we discuss domino hepatocyte transplantation (DHT) using livers that would not meet transplantation criteria.
dc.formatapplication/pdf
dc.languageeng
dc.publisherHindawi Publishing Corporation
dc.rightsopen access
dc.subjectInsuficiência Hepática Aguda
dc.subjectTratamento
dc.subjectTransplante de Hepatócitos Domino
dc.subjectAlternativa Terapêutica
dc.subjectAcute Liver Failure
dc.subjectTreatment
dc.subjectDomino Hepatocyte Transplantation
dc.subjectTherapeutic Alternative
dc.titleDomino Hepatocyte Transplantation: A Therapeutic Alternative for the Treatment of Acute Liver Failure
dc.typeArticle


Este ítem pertenece a la siguiente institución